Yeming Wu

1.4k total citations · 1 hit paper
31 papers, 1.0k citations indexed

About

Yeming Wu is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yeming Wu has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 16 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yeming Wu's work include Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Ubiquitin and proteasome pathways (5 papers). Yeming Wu is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Ubiquitin and proteasome pathways (5 papers). Yeming Wu collaborates with scholars based in China, United States and United Kingdom. Yeming Wu's co-authors include Lunzhi Dai, Yingming Zhao, Minjia Tan, Jef D. Boeke, Junbiao Dai, Zhongyi Cheng, Zhongyu Xie, Zhixiang Wu, Qiu-Dong Jiang and Jin‐Ao Duan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yeming Wu

30 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lysine Succinylation and Lysine Malonylation in Histones

2012 484 citations Zhongyu Xie, Junbiao Dai et al. Molecular & Cellular Proteomics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yeming Wu China	14	675	159	117	104	89	31	1.0k
Parul Gupta India	13	563 0.8×	115 0.7×	106 0.9×	42 0.4×	85 1.0×	26	846
Chandra Sekhar Bhol India	19	800 1.2×	221 1.4×	111 0.9×	61 0.6×	56 0.6×	33	1.2k
Rosalba Minelli Italy	19	478 0.7×	118 0.7×	178 1.5×	12 0.1×	32 0.4×	33	1.0k
Kewal Kumar Mahapatra India	17	781 1.2×	237 1.5×	111 0.9×	64 0.6×	51 0.6×	30	1.2k
Linlin Chang China	17	606 0.9×	143 0.9×	134 1.1×	26 0.3×	60 0.7×	48	1.0k
Appu Rathinavelu United States	18	599 0.9×	203 1.3×	241 2.1×	14 0.1×	60 0.7×	71	1.1k
Neelu Yadav United States	23	1.7k 2.4×	209 1.3×	137 1.2×	32 0.3×	74 0.8×	36	2.0k
Ramachandran Rashmi United States	15	717 1.1×	169 1.1×	136 1.2×	33 0.3×	42 0.5×	18	1.0k
Edwina N. Scott United Kingdom	10	430 0.6×	66 0.4×	281 2.4×	270 2.6×	39 0.4×	12	956

Countries citing papers authored by Yeming Wu

Since Specialization

Citations

This map shows the geographic impact of Yeming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeming Wu more than expected).

Fields of papers citing papers by Yeming Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeming Wu. The network helps show where Yeming Wu may publish in the future.

Co-authorship network of co-authors of Yeming Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yeming Wu. A scholar is included among the top collaborators of Yeming Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeming Wu. Yeming Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Desai, Ami V., Amy E. Armstrong, Cornelis M. van Tilburg, et al.. (2025). Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. European Journal of Cancer. 220. 115308–115308. 1 indexed citations

Hu, Xiaoxiao, Yilu Zhou, Charlotte Hill, et al.. (2024). Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification. British Journal of Cancer. 130(11). 1841–1854. 3 indexed citations

Liu, Xiaowei, Cheng Cheng, Xiaoxiao Hu, et al.. (2022). PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis. Cell Death and Disease. 13(2). 178–178. 31 indexed citations

Cheng, Cheng, et al.. (2022). KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor. Cellular Signalling. 100. 110447–110447. 6 indexed citations

Cheng, Cheng, et al.. (2021). 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1. International Journal of Medical Sciences. 18(14). 3214–3223. 5 indexed citations

Cheng, Cheng, et al.. (2021). XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. Journal of Experimental & Clinical Cancer Research. 40(1). 255–255. 19 indexed citations

Chen, Kai, Cheng Cheng, Junqi Zhang, et al.. (2020). MYT1 attenuates neuroblastoma cell differentiation by interacting with the LSD1/CoREST complex. Oncogene. 39(21). 4212–4226. 13 indexed citations

Chen, Kai, et al.. (2020). Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway. Frontiers in Oncology. 10. 575366–575366. 13 indexed citations

Gu, Yuting, Mingxing Xue, Kai Chen, et al.. (2018). The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. Journal of Experimental & Clinical Cancer Research. 37(1). 258–258. 34 indexed citations

10.

Gu, Yuting, Xinyuan Ding, Jiefang Huang, et al.. (2018). The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells. Cell Death and Disease. 9(5). 459–459. 38 indexed citations

11.

Chen, Kai, et al.. (2017). Proteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factors. Journal of Proteomics. 160. 55–63. 7 indexed citations

12.

Zhang, Min, et al.. (2017). Legumain correlates with neuroblastoma differentiation and can be used in prodrug design. Chemical Biology & Drug Design. 91(2). 534–544. 6 indexed citations

13.

Wang, Yue, Yongtao Xiao, Kai Chen, et al.. (2016). Enhancer of zeste homolog 2 depletion arrests the proliferation of hepatoblastoma cells. Molecular Medicine Reports. 13(3). 2724–2728. 3 indexed citations

14.

Chen, Sheng, et al.. (2016). Exposure to pyrethroid pesticides and the risk of childhood brain tumors in East China. Environmental Pollution. 218. 1128–1134. 70 indexed citations

15.

Chen, Sheng, et al.. (2015). HIF-1α Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling. PLoS ONE. 10(3). e0121115–e0121115. 47 indexed citations

16.

Wu, Yeming, et al.. (2014). Preliminary analysis of stem cell-like cells in human neuroblastoma. World Journal of Pediatrics. 11(1). 54–60. 9 indexed citations

17.

Xu, Guofeng, et al.. (2013). Botryoid Wilms’ tumor: a case report and review of the literature. World Journal of Surgical Oncology. 11(1). 102–102. 7 indexed citations

18.

Xu, Guofeng, et al.. (2013). The Combined Effect of Retinoic Acid and LSD1 siRNA Inhibition on Cell Death in the Human Neuroblastoma Cell Line SH-SY5Y. Cellular Physiology and Biochemistry. 31(6). 854–862. 5 indexed citations

19.

Du, Lei, et al.. (2013). Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. Journal of Pediatric Surgery. 49(4). 528–533. 16 indexed citations

20.

Xie, Zhongyu, Junbiao Dai, Lunzhi Dai, et al.. (2012). Lysine Succinylation and Lysine Malonylation in Histones. Molecular & Cellular Proteomics. 11(5). 100–107. 484 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact